Understanding Widespread Mutation Testing For Nsclc
Exploring Widespread Mutation Testing For Nsclc reveals several interesting facts. Geoffrey R. Oxnard, MD, and Sandip Patel, MD, describe the value of large panel genetic profiling for metastatic non–small cell ...
Key Takeaways about Widespread Mutation Testing For Nsclc
- In this segment the panelists discuss the important
- Geoffrey R. Oxnard, MD, and Sandip Patel, MD, discuss the use of plasma-based genetic profiling of EGFR and ALK resistance ...
- The importance of
- Alice Shaw, MD, PhD, and Tony Mok, MD, provide insight on the role of
- Roy S. Herbst, MD, PhD; Bruce E. Johnson, MD; and Mark A. Socinski, MD, discuss the role of genetic
Detailed Analysis of Widespread Mutation Testing For Nsclc
Sarah Goldberg, MD, describes the role of Luis Raez, MD, and Ben Levy, MD, discuss the role of next-generation sequencing for patients with non–small cell In this segment, Benjamin Levy, MD, discusses current recommendations for genetic
Corey J. Langer, MD, discusses the use of
Stay tuned for more updates related to Widespread Mutation Testing For Nsclc.